Nature CommunicationsPharmacology & ToxicologyPeer-reviewed journal article
Enantioselective Protein Affinity Selection Mass Spectrometry (E-ASMS)
Xiaoyun WangiD, Jianxian SuniD, Shabbir AhmadiD, Diwen YangiD, Fengling LiiD, U Hang ChaniD, Hong Zeng, Conrad Veranso SimobeniD, Stuart R. GreeniD, Madhushika SilvaiD, Scott HoulistoniD, Aiping DongiD, Albina Bolotokova, Elisa GibsoniD, Maria Kutera, Pegah Ghiabi, Ivan S. KondratoviD, Tetiana MatviiukiD, Alexander ChuprinaiD, Danai MavridiiD, Christopher LenziD, Andreas C. JoergeriD, Benjamin D. Brown, Richard B. Heath, Wyatt W. YueiD, , Levon HalabelianiD
Abstract
We report an enantioselective protein affinity selection mass spectrometry screening approach (E-ASMS) that enables the detection of weak binders, informs on selectivity, and generates orthogonal confirmation of binding. After method development with control proteins, we screened 31 human proteins against a designed library of 8,210 chiral compounds. 16 binders to 12 targets, including many proteins predicted to be "challenging to ligand", were discovered and confirmed in orthogonal biophysical assays. 7 binders to 6 targets bound in an enantioselective manner, with KD values ranging from 3 to 20 {micro}M. Binders for four targets (DDB1, WDR91, WDR55, and HAT1) were selected for in-depth characterization using X-ray crystallography. In all four cases, the mechanism for enantioselectivity was readily explained. We conclude E-ASMS can be used to identify and characterize selective and weakly-binding ligands for novel protein targets with unprecedented throughput and sensitivity.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 9
- FWCI
- 2.28
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Affinity Selection-Mass Spectrometry Coupled with Biophysical Validation Enables Proof-of-Concept Discovery of CHI3L1 Binders
Baljit Kaur, Hossam Nada, Moustafa Tarek Gabr·Biochemical and Biophysical Research CommunicationsPeer-reviewed·Oct 10, 2025
- Affinity-mass spectrometric technologies for quantitative proteomics in biological fluids
Huiyan Li, Robert Popp, Christoph H. Borchers·TrAC Trends in Analytical ChemistryPeer-reviewed·Mar 2, 2017
- PANCS-spec-Binders: A system for rapidly discovering isoform- or epitope-specific binders
Joshua A. Pixley, Matthew J. Styles, … Bryan C. Dickinson·Proceedings of the National Academy of SciencesPeer-reviewed·Jun 2, 2026
- Identification of a First-In-Class Small Molecule CAPON Binder Using Affinity Selection-Mass Spectrometry Screening
Ashraf N. Abdo, Hossam Nada, Moustafa Tarek Gabr·bioRxiv·Nov 5, 2025
- High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compounds
Diwen Yang, Xiaoyun Wang, … Hui Peng·Proceedings of the National Academy of SciencesPeer-reviewed·Jun 5, 2026
- High-throughput protein binder discovery by rapid in vivo selection
Matthew J. Styles, Joshua A. Pixley, … Bryan C. Dickinson·bioRxiv·Jan 6, 2025